Toxoid Vaccine Market Size, Share 2024, Impressive Industry Growth Report 2031
The global toxoid vaccine market is expected to grow at a significant CAGR during the forecast period (2024-2031). The key companies across the globe are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers and acquisitions, geographical expansion, new product launch, and product innovation to remain competitive in the marketplace. For instance, in March 2020, In December 2019, Panacea Biotec, received an award worth $24.3 million from U. N nations (UNICEF and PAHO) for its supply of its WHO prequalified Pentavalent Vaccine. The vaccine protects children from Diphtheria, Tetanus, Pertussis, hepatitis B, and invasive infections caused by Haemophilus Influenza Type b.
Get Free Sample link @ https://www.omrglobal.com/request-sample/toxoid-vaccine-market-size
Apart from this, in May 2021, GlaxoSmithKline and Samsung partnered to provide GSK with additional capacity to manufacture and supply GSK's innovative biopharmaceutical therapies. The agreement will supplement GSK's existing manufacturing network. Moreover, in April 2021, AstraZeneca proposed acquisition of Alexion Pharmaceuticals, Inc received US Federal Trade Commercial clearance. In addition, in June 2021, Merck acquired the spinoff of Organon & Co. Merck. The acquisition will allow Merck to create two patient-focused companies with enhanced strategies, operational focus, and improved financial profiles. In October 2018, Emergent Biosolutions Inc. acquired PaxVax to expand its portfolio of marketed and pipeline products, expand its manufacturing capabilities and strengthen its presence in the market.
The factor contributing to the growth of the market is the rising prevalence of tetanus. According to the Center for disease control and prevention, 38,000 people died from tetanus in 2017, across the globe, and around half (49%) were younger than five years old. Additionally, the vaccine against tetanus allowed progress in controlling the disease. 89% reduction in tetanus cases and deaths resulted since 1990. Thus, the usefulness of vaccines is contributing to the growth of the market.
Full report of Toxoid Vaccine Market available @ https://www.omrglobal.com/industry-reports/toxoid-vaccine-market-size
Market Coverage
Competitive Landscape: Pfizer Inc., Merck KGaA, and GlaxoSmithKline PLC, among others.
Key questions addressed by the report
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
Global Toxoid Vaccine Market Report Segmentation
By Type
By End-User
Reasons to Buying From us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/toxoid-vaccine-market-size
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Please complete the following requested information to flag this post and report abuse, or offensive content. Your report will be reviewed within 24 hours. We will take appropriate action as described in Findit terms of use.